Skip to main content

Table 3 Multivariable Cox’s proportional hazard regression model to predict overall survival in the subgroup (10 LNs as Pentafecta threshold)

From: External validation of Pentafecta in patients undergoing laparoscopic radical cystectomy: results from a high-volume center

Variable HR (95% CI) P value
Sex (male vs. female) 0.72 (0.38–1.38) 0.325
Age (≤ 65 vs. > 65) 1.07 (0.63–1.81) 0.817
Diversion type (conduit vs. cutaneous ureterostomy) 1.31 (0.80–2.16) 0.289
Diversion type (neobladder vs. cutaneous ureterostomy) 0.79 (0.36–1.84) 0.476
Pathological T-stage (MIBC vs. NMIBC) 4.96 (2.61–9.40) < 0.001
Pathological N-stage (N + vs. N−) 2.86 (1.31–6.22) 0.008
Smoking history (yes vs. no) 0.92 (0.55–1.55) 0.756
Neoadjuvant chemotherapy (yes vs. no) 0.92 (0.32–2.61) 0.870
Pentafecta (10 LNs) (yes vs. no) 0.31 (0.11–0.89) 0.029